I am excited to share that Gameto has closed a $33M Series B fundraising round, led by Two Sigma Ventures and RA Capital Management, with participation from existing investors Insight Partners, Future Ventures, and BOLD Capital Partners among others. Our investor group is also joined by Ingeborg Investments, Amplifyher Ventures, Stacey Bendet Eisner, Founder, CEO, and Creative Director of alice + olivia, and Chelsea M.R. Hirschhorn, Founder and CEO of Frida. This funding brings Gameto’s total capital raised to date to $73M.
We are honored to have added the teams at Two Sigma, RA Capital, and others to our stellar investor base, and we are pleased to see increased investor confidence in our platform technology and a recognition of the pressing need for modern treatments in the historically underfunded women's health space, despite a challenging market. I believe that each small step we take in investing in women’s health can lead to a giant leap in medical breakthroughs and innovation.
A fundraising round is not a milestone per se but a way to continue amplifying one’s work. I strongly believe that Gameto has strong foundational science, promising data, and a highly driven team and I am very excited about using these funds to continue amplifying our hard work. These funds will support our late stage clinical development in the United States, post-market surveillance outside the US, and the creation of a commercial operations function for our lead product candidate, Fertilo, which aims to improve IVF and egg freezing by reducing the number of hormone injections needed by maturing eggs outside the body in a dish.
When I moved to New York City for the first time, I was considering my own egg freezing and I had a dream that a woman could freeze her eggs and do IVF without weeks of painful hormonal injections. It is unreal how far we have come. We have changed, learned a lot, and grown, but still have a long way to go.
This raise was a team effort and product of the hard work of all Gameto team members, board members and advisors.
Martin Varsavsky, Dylan Morris, Maryanna Saenko, Teymour Boutros-Ghali, Dusan Perovic, Laura Stoppel, Peter Kolchinsky, Mira Kaufman, Anna Mason, Deena Shakir, Leslie Schrock, Kristina Simmons
We are expanding the team now and currently looking for a Chief Medical Officer, Commercial Operations Lead, and a Science Writer, so check out our website career page if you are passionate about our mission and think you are a good fit for any of the open positions.
Link to our full Series B press release here: https://lnkd.in/gYCQggzy
It's great to see such strong collaborations. How has this partnership impacted your recent projects?